Abstract
To describe the clinical, spectroscopic and neuropsychological features of the first family diagnosed with a defect in the creatine transporter.
Proton Magnetic Resonance Spectroscopy (MRS) indicated an absence of creatine and phosphocreatine in the brain of a male patient characterized by developmental delay, mild epilepsy and severe expressive language impairment. Subsequent genetic testing revealed a defect in the X-linked creatine transporter (SLC6A8/CT1), with a hemizygous mutation in the patient and a heterozygous mutation for the female carriers.
Magnetic resonance imaging and spectroscopy examinations were performed on a 1.5T clinical MR Scanner. Neuropsychological examinations were performed on the index patient and maternal relatives.
Preliminary spectroscopy results indicate the disorder prevents transport of creatine and phosphocreatine in the brain of the affected male. However, the skeletal muscle demonstrates the presence of creatine and phosphocreatine which correlates clinically with normal structure and function. Female carriers demonstrated impairments in confrontational naming and verbal memory assessments.
This new neurological syndrome is associated with developmental delay, mild epilepsy, severe language impairment. MR Spectroscopy is a non-invasive method for obtaining a preliminary diagnosis of this disorder. Muscle creatine uptake may be normal in this disorder.
Similar content being viewed by others
References
Stockler S, Hozbach U, Hanefeld F: Creatine deficiency in the brain: A new, treatable inborn error of metabolism. Pedatr Res 36: 509-413, 1994
Item CB, Stockler-Ipsiroglu S, Stromberger C, Muhl A, Alessandri MG, Bianchi MC, Tosetti M, Fornai F, Cioni G: Arginine: Glycine amidinotransferase (AGAT) deficiency: The third inborn error of creatine metabolism. J Inherit Metab Dis 24: 118, 2001
Cecil KM, Salomons GS, Ball WS Jr, Wong B, Chuck G, Verhoeven NM, Jakobs C, DeGrauw TJ: Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect? Ann Neurol 49: 401-404, 2001
Salomons GS, van Dooren SJ, Verhoeven NM, Ecil KM, Ball WS, DeGrauw TJ, Jakobs C: X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome. Am J Hum Genet 68: 1497-1500, 2001
Bayley N: In: Bayley Scales of Infant Development. The Psychological Corporation, San Antonio, 1993
Sparrow SS, Balla DA, Cicchetti DV: In: Vineland Adaptive Behavior Scales. American Guidance Service, Circle Pines, MN, 1984
Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation, San Antonio, 1999
Wilkinson G: In: Wide Range Achievement Test, Revision Three. Wide Range Inc., Wilmington, DE, 1993
Snow RJ, Murphy RM: Creatine and the creatine transporter: A review. Mol Cell Biochem 224: 169-181, 2001
Ensenauer R: Presence of muscle creatine in a patient with guanidinoacetate methyltransferase (GAMT) deficiency. J Inherit Metab Dis 23: 212, 2000
Trauner D, Wulfeck B, Tallal P, Hesselink J: Neurological and MRI profiles of children with developmental language impairment. Dev Med Child Neurol 42: 470-475, 2000
Rae C, Lee MA, Dixon RM, Blamire AM, Thompson CH, Styles P, Talcott J, Richardson AJ, Stein JF: Metabolic abnormalities in developmental dyslexia detected by 1H magnetic resonance spectroscopy. Lancet 351: 1849-1852, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Grauw, T.J., Cecil, K.M., Byars, A.W. et al. The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 244, 45–48 (2003). https://doi.org/10.1023/A:1022487218904
Issue Date:
DOI: https://doi.org/10.1023/A:1022487218904